IJGC Podcast

By BMJ GroupMedicine Health & Fitness

IJGC Podcast episodes

March 10, 2021 Reviewing the March Issue with Enrique Chacon (Spanish Version)
In this episode of the IJGC Podcast, Editorial Fellow Enrique Chacon discusses the contents of the March issue in Spanish.
19 min
March 09, 2021 Reviewing the March Issue with Nicolò Bizzarri (Italian Version)
In this episode of the IJGC Podcast, Editorial Fellow Nicolò Bizzarri discusses the contents of the March issue in Italian.
17 min
March 09, 2021 International ABRAX Study with David Cibula
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. David Cibula to discuss the international ABRAX study. Dr. Cibula is the Chair of the Gynecologic Oncology Center at the General Faculty Hospital in Prague, Chair of the Central and Eastern European Gynaecologic Oncology Group (CEEGOG), as well as a Former ESGO president.
Highlights:
* ABRAX trial was designed to evaluate if the completion of radical hysterectomy is associated with a survival benefit in patients with early-stage cervical cancer and positive pelvic lymph node found intraoperatively.
* This trial represents the largest cohort of patients managed by upfront surgery with negative lymph nodes on preoperative staging but positive lymph node involvement diagnosed during surgery.
* We did not find any improvement in PFS, OS, or pelvic disease-free survival associated with radical hysterectomy, either in the whole group or in any subgroups, including patients with larger tumor size or adenocarcinomas.
* The outcome of the ABRAX trial is in agreement with current international guidelines (NCCN, ESGO-ESTRO-ESP) which recommend the abandonment of further radical surgery in patients with intraoperative N1 detection.
48 min
March 05, 2021 Conservative Management of Endometrial Cancer with Olga Novikova
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Olga Novikova to discuss the conservative management of endometrial cancer.
Highlights
1) Levonorgestrel-releasing IUD containing regimens are found superior to oral medroxyprogesterone in both atypical hyperplasia and early endometrial cancer patients.
2) ART when used did not affect the recurrence rates which makes it safe to recommend to improve pregnancy rates.
3) Live births and maintenance with Levonorgestrel-releasing IUD did significantly improve disease-free survival after fertility-sparing treatment.
29 min
March 03, 2021 Reviewing the March Issue with Irina Tsibulak (Russian Version)
In this episode of the IJGC Podcast, Editorial Fellow Irina Tsibulak discusses the contents of the March issue in Russian.
14 min
February 26, 2021 Reviewing the March Issue with Anna Collins and Nicolò Bizzarri (English Version)
In this episode of the IJGC Podcast, Editorial Fellows Anna Collins and Nicolò Bizzarri discuss the contents of the March issue.
16 min
February 17, 2021 STAR Trial with Ji-Hong Liu
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Ji-Hong Liu to discuss the STAR Trial. Dr. Liu is a Professor in the Department of Gynecologic Oncology at Sun Yat-sen University Cancer Center. He is also President-elect of the Gynecologic Oncology Committee of China Anti-Cancer Association.
Highlights:
- In post-surgery treatment setting, adjuvant sequential chemoradiation was associated with improved disease-free survival compared with radiation alone or concurrent chemoradiation, and was well tolerated.
- Sequential chemoradiation also decreased the risk of death compared with radiation alone.
- Neither disease-free survival nor cancer death risk was different between patients treated with concurrent chemoradiation or radiation alone.
- The detailed QOL results in comparisons between three arms will be orally presented at the annual meeting of SGO 2021 in March.
- In conclusion, sequential chemoradiation (SCRT) after radical surgery resulted in a better disease-free survival and lower risk of cancer death for cervical cancer patients with adverse pathological factor, and could be an optimal adjuvant treatment in this setting.
36 min
February 17, 2021 Reviewing the February Issue with Enrique Chacon (Spanish Version)
In this episode of the IJGC Podcast, Editorial Fellow Enrique Chacon discusses the contents of the February issue in Spanish.
12 min
February 17, 2021 Reviewing the February Issue with Nicolò Bizzarri (Italian Version)
In this episode of the IJGC Podcast, Editorial Fellow Nicolò Bizzarri discusses the contents of the February issue in Italian.
15 min
February 17, 2021 Reviewing the February Issue with Alex Mutombo (French Version)
In this episode of the IJGC Podcast, Editorial Fellow Alex Mutombo discusses the contents of the February issue in French.
13 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.